Does ERENUMAB-AOOE Cause Mobility decreased? 660 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 660 reports of Mobility decreased have been filed in association with ERENUMAB-AOOE. This represents 1.3% of all adverse event reports for ERENUMAB-AOOE.
660
Reports of Mobility decreased with ERENUMAB-AOOE
1.3%
of all ERENUMAB-AOOE reports
581
Deaths
548
Hospitalizations
How Dangerous Is Mobility decreased From ERENUMAB-AOOE?
Of the 660 reports, 581 (88.0%) resulted in death, 548 (83.0%) required hospitalization, and 540 (81.8%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERENUMAB-AOOE. However, 660 reports have been filed with the FAERS database.
What Other Side Effects Does ERENUMAB-AOOE Cause?
Accidental exposure to product (9,923)
Device difficult to use (9,530)
Wrong technique in product usage process (9,359)
Drug dose omission by device (6,340)
Migraine (4,290)
Drug ineffective (3,813)
Constipation (3,104)
Product storage error (2,958)
Headache (2,787)
Injection site pain (2,715)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which ERENUMAB-AOOE Alternatives Have Lower Mobility decreased Risk?
ERENUMAB-AOOE vs ERENUMAB\ERENUMAB-AOOE
ERENUMAB-AOOE vs ERGOCALCIFEROL
ERENUMAB-AOOE vs ERGOCALCIFEROL\PHYTONADIONE\RETINOL\TOCOPHEROL
ERENUMAB-AOOE vs ERIBULIN
ERENUMAB-AOOE vs ERLOTINIB